> top > docs > PMC:7205724 > spans > 287-507 > annotations

PMC:7205724 / 287-507 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
5 44-52 Disease denotes COVID-19 MESH:C000657245
7 127-135 Disease denotes COVID-19 MESH:C000657245
10 140-143 Gene denotes IL6 Gene:3569
11 212-220 Disease denotes COVID-19 MESH:C000657245

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T2 44-52 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T3 127-135 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T4 212-220 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T5 107-122 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858

LitCovid-sample-MedDRA

Id Subject Object Predicate Lexical cue meddra_id
T2 183-193 http://purl.bioontology.org/ontology/MEDDRA/10022891 denotes viral load http://purl.bioontology.org/ontology/MEDDRA/10062178

LitCovid-sample-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T4 107-122 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858

LitCovid-sample-PD-NCBITaxon

Id Subject Object Predicate Lexical cue ncbi_taxonomy_id
T2 44-52 Species denotes COVID-19 NCBItxid:2697049
T3 127-135 Species denotes COVID-19 NCBItxid:2697049
T4 212-220 Species denotes COVID-19 NCBItxid:2697049

LitCovid-sample-sentences

Id Subject Object Predicate Lexical cue
T7 54-136 Sentence denotes • No controlled clinical trials exist on the use of corticosteroids for COVID-19.

LitCovid-sample-Pubtator

Id Subject Object Predicate Lexical cue pubann:denotes
5 44-52 Disease denotes COVID-19 MESH:C000657245
7 127-135 Disease denotes COVID-19 MESH:C000657245
10 140-143 Gene denotes IL6 Gene:3569
11 212-220 Disease denotes COVID-19 MESH:C000657245

LitCovid-sample-UniProt

Id Subject Object Predicate Lexical cue uniprot_id
T1 140-143 Protein denotes IL6 https://www.uniprot.org/uniprot/Q9XT80|https://www.uniprot.org/uniprot/Q9UCU4|https://www.uniprot.org/uniprot/Q9UCU3|https://www.uniprot.org/uniprot/Q9UCU2|https://www.uniprot.org/uniprot/Q9MZR1|https://www.uniprot.org/uniprot/Q9MYZ7|https://www.uniprot.org/uniprot/Q95KN6|https://www.uniprot.org/uniprot/Q95181|https://www.uniprot.org/uniprot/Q90YI0|https://www.uniprot.org/uniprot/Q8MKH0|https://www.uniprot.org/uniprot/Q8BN26|https://www.uniprot.org/uniprot/Q865X6|https://www.uniprot.org/uniprot/Q865W7|https://www.uniprot.org/uniprot/Q6V919|https://www.uniprot.org/uniprot/Q6L6X6|https://www.uniprot.org/uniprot/Q5I6E3|https://www.uniprot.org/uniprot/Q3UCQ0|https://www.uniprot.org/uniprot/Q2MH06|https://www.uniprot.org/uniprot/Q28819|https://www.uniprot.org/uniprot/Q28747|https://www.uniprot.org/uniprot/Q28319|https://www.uniprot.org/uniprot/Q25BC2|https://www.uniprot.org/uniprot/Q0PW36|https://www.uniprot.org/uniprot/Q0GGL7|https://www.uniprot.org/uniprot/Q08DT2|https://www.uniprot.org/uniprot/P79341|https://www.uniprot.org/uniprot/P51494|https://www.uniprot.org/uniprot/P46650|https://www.uniprot.org/uniprot/P41693|https://www.uniprot.org/uniprot/P41683|https://www.uniprot.org/uniprot/P41323|https://www.uniprot.org/uniprot/P29455|https://www.uniprot.org/uniprot/P26893|https://www.uniprot.org/uniprot/P26892|https://www.uniprot.org/uniprot/P20607|https://www.uniprot.org/uniprot/P08505|https://www.uniprot.org/uniprot/P05231|https://www.uniprot.org/uniprot/O46568|https://www.uniprot.org/uniprot/O35736|https://www.uniprot.org/uniprot/O19007|https://www.uniprot.org/uniprot/B6CKP4|https://www.uniprot.org/uniprot/A9QWQ9|https://www.uniprot.org/uniprot/A3FBE9|https://www.uniprot.org/uniprot/A0S0B0

LitCovid-sample-Enju

Id Subject Object Predicate Lexical cue
T42 13-18 MD denotes might
T43 19-29 VB denotes accelerate
T44 30-38 NN denotes recovery
T45 39-43 IN denotes from
T46 44-52 NN denotes COVID-19
T47 54-55 PDT denotes •
T48 57-59 DT denotes No
T49 60-70 VBN denotes controlled
T50 71-79 JJ denotes clinical
T51 80-86 NNS denotes trials
T52 87-92 VBP denotes exist
T53 93-95 IN denotes on
T54 96-99 DT denotes the
T55 100-103 NN denotes use
T56 104-106 IN denotes of
T57 107-122 NNS denotes corticosteroids
T58 123-126 IN denotes for
T59 127-135 NN denotes COVID-19
T60 137-138 LS denotes •
T61 140-143 NN denotes IL6
T62 144-154 VBZ denotes correlates
T63 155-159 IN denotes with
T64 160-168 NN denotes severity
T65 168-169 -COMMA- denotes ,
T66 170-181 NN denotes criticality
T67 181-182 -COMMA- denotes ,
T68 183-188 JJ denotes viral
T69 189-193 NN denotes load
T70 193-194 -COMMA- denotes ,
T71 195-198 CC denotes and
T72 199-208 NN denotes prognosis
T73 209-211 IN denotes of
T74 212-220 NN denotes COVID-19
R38 T43 T42 arg2Of accelerate,might
R40 T44 T43 arg2Of recovery,accelerate
R41 T44 T45 arg1Of recovery,from
R42 T46 T45 arg2Of COVID-19,from
R43 T51 T47 arg1Of trials,•
R44 T51 T48 arg1Of trials,No
R45 T51 T49 arg2Of trials,controlled
R46 T51 T50 arg1Of trials,clinical
R47 T51 T52 arg1Of trials,exist
R48 T52 T53 arg1Of exist,on
R49 T55 T53 arg2Of use,on
R50 T55 T54 arg1Of use,the
R51 T55 T56 arg1Of use,of
R52 T57 T56 arg2Of corticosteroids,of
R53 T55 T58 arg1Of use,for
R54 T59 T58 arg2Of COVID-19,for
R55 T62 T60 arg1Of correlates,•
R56 T61 T62 arg1Of IL6,correlates
R57 T62 T63 arg1Of correlates,with
R58 T71 T63 arg2Of and,with
R59 T64 T65 arg1Of severity,","
R60 T66 T65 arg2Of criticality,","
R61 T65 T67 arg1Of ",",","
R62 T69 T67 arg2Of load,","
R63 T69 T68 arg1Of load,viral
R64 T71 T70 arg1Of and,","
R65 T67 T71 arg1Of ",",and
R66 T72 T71 arg2Of prognosis,and
R67 T72 T73 arg1Of prognosis,of
R68 T74 T73 arg2Of COVID-19,of

LitCovid-sample-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T2 44-52 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T3 127-135 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T4 212-220 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T7 54-136 Sentence denotes • No controlled clinical trials exist on the use of corticosteroids for COVID-19.